+ All Categories
Home > Documents > Financing Development and Expansion

Financing Development and Expansion

Date post: 27-Dec-2021
Category:
Upload: others
View: 3 times
Download: 0 times
Share this document with a friend
14
1 Financing Development Financing Development and Expansion and Expansion Sponsored by: Lilly Oncology Sponsored by: Lilly Oncology Grant R. Chamberlain Managing Director, Shattuck Hammond Partners Peter S. Myhre Chief Executive Officer, MarCap Corporation 2 Access to Capital Access to Capital Projects or new business enterprises can be financed through multiple channels: Debt Markets – Tax-Exempt – Taxable – Vendor Equity Markets Venture Capital – Angels Partnership Models Alternative Sources Government supported initiatives – Philanthropy
Transcript
Page 1: Financing Development and Expansion

1

Financing DevelopmentFinancing Developmentand Expansionand Expansion

Sponsored by: Lilly OncologySponsored by: Lilly Oncology

Grant R. ChamberlainManaging Director, Shattuck

Hammond Partners

Peter S. MyhreChief Executive Officer, MarCap

Corporation

2

Access to CapitalAccess to Capital

Projects or new business enterprises can be financed through multiple channels:

• Debt Markets– Tax-Exempt– Taxable– Vendor

• Equity Markets– Venture Capital– Angels

• Partnership Models• Alternative Sources

– Government supported initiatives

– Philanthropy

Page 2: Financing Development and Expansion

2

3

Equity CapitalEquity CapitalEquity capital to support well-grounded business

models is readily available.

0

2

4

6

8

10

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2

2003 2004 2005 2006 2007

Ven

ture

Cap

ital

0

50

100

150

200

250

300

350

400

HC

Venture C

apital

HC Venture Capital $ Amount Venture Capital $ Amount

$4.3B691 deals

$5.0B736 deals

$4.9B710 deals

$5.6B777 deals

$5.3B707 deals

$6.3B850 deals

$5.0B684 deals

$5.9B828 deals

$5.1B721 deals

$6.3B817 deals $5.9B

781 deals

$5.8B808 deals

$6.4B856 deals

$7.0B920 deals $6.7B

885 deals

$6.2B892 deals

$7.4B854 deals

$7.1B977 deals

$79M16 deals

$36M12 deals

$54M19 deals

$83M22 deals

$50M14 deals

$184M19 deals

$68M16 deals

$99M17 deals

$89M15 deals

$109M17 deals

$67M16 deals

$141M19 deals $124M

22 deals

$80M10 deals

$78M11 deals

$129M15 deals

$161M10 deals

$22M8 deals

4

EquityEquity CapitalCapital (cont(cont’’d)d)

Driven by the increased availability of debt capital over past 6 years, valuations have correspondingly increased each year.

2.7 x 3.0 x 2.8 x3.2 x

3.8 x 3.9 x4.5 x

x 0.9x 0.9 x 1.3

x 1.5

x 1.5 x 1.4

x 1.6

0.0 x

1.0 x

2.0 x

3.0 x

4.0 x

5.0 x

6.0 x

7.0 x

2001 2002 2003 2004 2005 2006 YTD

Tota

l Deb

t/EB

ITD

A

Senior Debt/EBITDA Subordinated Debt/EBITDA

3.9 x 4.1 x

4.7 x

3.6 x

5.2x 5.3x

6.1x

6.4 x6.7 x 6.8 x

7.2 x

8.1 x8.4 x

9.0 x

4.0 x

5.0 x

6.0 x

7.0 x

8.0 x

9.0 x

2001 2002 2003 2004 2005 2006 YTD

Mea

n M

ultip

le

Page 3: Financing Development and Expansion

3

5

Equity CapitalEquity Capital (cont(cont’’d)d)

Private equity is flowing into several healthcare services sectors that support various cancer services models:

• Re-emergence of physician practice management companies = Lessons Learned– Single specialty focus

• Oncology• Urology• Pathology• Anesthesiology

– “PhyCor” Model Structures

• Outpatient Service Models– Radiation Therapy– Proton Therapy– Gamma Knife– PET/CT

• Molecular Science – Genetics driven businesses

6

Halpern, Denny & Co.

Selected Healthcare Private Equity Selected Healthcare Private Equity InvestorsInvestors

Page 4: Financing Development and Expansion

4

7

Investor Growth Capital

Selected Healthcare Private Equity Selected Healthcare Private Equity Investors Investors (cont(cont’’d)d)

8

Private Equity Backed ParticipantsPrivate Equity Backed ParticipantsPrivate equity generally has a different set of business

mandates, in comparison to debt capital providers, when assessing an investment opportunity.

• Growth, growth, growth– De Novo or through acquisitions– Regional, national or global aspirations– Expansive service lines

• Unique, business model– Replicable– Intellectual property

• Seasoned management talent• Identifiable exit

Page 5: Financing Development and Expansion

5

9

Debt: Funding Options and Debt: Funding Options and Sources of CapitalSources of Capital

10

Ownership ModelsOwnership Models

Physician-Owned

Physicians

+

Developer

Physicians

+

Hospital

Physicians

+

Hospital

+

Developer

Page 6: Financing Development and Expansion

6

11

What Are Your Financing Options?What Are Your Financing Options?

Risk/Pricing

HigherLower

MoreLess

Local Banks National Banks Leasing Companies

Flexibility

12

What Does a Financing Company What Does a Financing Company Look For?Look For?• Physicians: reliability of patient referrals• Track record of developer• Knowledge of the market• Commitment from physicians, developer and/or hospital

– Equity– Guarantees

• Adequate equity contribution (at least 20 to 25 percent)• Sufficient working capital (at least 4 to 6 months’

expenses)

Page 7: Financing Development and Expansion

7

13

Types of LoansTypes of LoansNeed a certain amount of equity and the rest can be

financed:

TenantImprovements

Real EstateFinancing

EquipmentFinancing

WorkingCapital

14

Loan/Lease Structure OptionsLoan/Lease Structure Options

• Zero and interest only payments during start up period• Step payments

(amount increases or decreases over time)• Terms of 60 to 84 months• Include vault costs and some tenant improvements

financing• Working capital back-up line of credit• Fair market value leases available• Fee for scan or fee for use

Page 8: Financing Development and Expansion

8

15

Model Developers/OperatorsModel Developers/Operators

16

• Joint venture with hospitals to provide stereotacticradiosurgery (SRS)

• The doctors select the equipment and take an equity position

• Hospital, physicians and Accelitech provide equity; Accelitech provides ongoing management

Developer: Developer: AccelitechAccelitech

Page 9: Financing Development and Expansion

9

17

• Developer, manager and investor in SRS projects that include physician ownership, and often a hospital partner

• They are private equity backed and, therefore, have equity to invest in projects

Developer: U.S. Developer: U.S. RadiosurgeryRadiosurgery

18

• Developer of radiation therapy cancer treatment facilities

• Establish turn-key cancer treatment facilities for urology groups

• Often facilitate the joint venture or merger of smaller urology groups to obtain adequate patient volume and scale

• Their focus is developing and managing the center leaving 100% ownership to the doctors

Developer: USMDDeveloper: USMD

Page 10: Financing Development and Expansion

10

19

Transaction: New JV between hospitals and local physicians Cancer center located on hospital campus10 year fee-for-procedure with the hospitalLimited local competitionDoctors provided $1M in working capitalHospital strong financiallyBuilding and leaseholds were directly funded by the hospitalProve-up correlated by feasibility study, cancer incidence rateStrong support by community and hospital physicians

Funding Provided: $5,500,000Equipment: New Accuray Cyberknife

New GE 16/S CTStructure: Term: 84 months

Credit Enhancements: Assignment of “fee-for-procedure” contract

Sample Transaction #1Sample Transaction #1

20

Transaction: Acquisition financing of existing CyberKnife center

Funding Provided: $5.4M

Structure: Term: 66 months

Payments: 1-3 @ $04-6 Half level payments7-66 Level payments fully amortizing

• Purpose: Finance acquisition of JV between developer, local hospital, and eight physicians (6 Radiation Oncologists, 1 Urologist, 1 Thoracic Surgeon) for an existing SRS CyberKnife center

• Provided a facility comprised of a loan for $3.75M term loan for equipment, $1.15M to pay off tenant improvement debt, and $500k to pay off existing working capital facility

• Customer provided $800k working capital• No Guarantees• Hospital admits patients and handles all billing & collecting

Sample Transaction #2Sample Transaction #2

Page 11: Financing Development and Expansion

11

21

Transaction: De novo CyberKnife centerFunding Provided: $5.0MEquipment: $3.85MStructure: Term: 66 months

Payments: 1-3 @ $04-6 Half level payments7-66 Level payments fully amortizing

• Purpose: Finance JV between developer, local hospital, one existing Radiation Oncology practice, one existing Neurosurgery practice, and eight other Neurosurgeons for a de novo SRS CyberKnife center

• Financing included $3.85M for equipment, $1M for tenant improvements, and $150k for FFE

• Customer provided $500k working capital• No Guarantees• Hospital admits patients and handles all billing & collecting

Sample Transaction #3 Sample Transaction #3

22

Transaction: De novo Cancer Treatment Center using IMRT and IGRT

Funding Provided: $5 Million

Equipment: GRT Equipment, Vault, CT, and Tenant Improvements

Structure: Term: 84 Month Capital Lease Payments 1-3 @ $0.00Payments 4-6 @ Interest OnlyPayments 7-84 full amortization of the total debt remaining

• Purpose – Finance Cancer Treatment Equipment, Tenant Improvements, Etc. for a 16 man Urology group

• Provided a facility that financed the Cancer Treatment Center Equipment needs with 100% financing, with no Personal Guarantees of the Physicians

• Transaction was secured by the Equipment Collateral and the Accounts Receivables of the Cancer Treatment Center

Sample Transaction #4Sample Transaction #4

Page 12: Financing Development and Expansion

12

23

Transaction: Start-up Radiation Therapy Center located in SW USASingle Radiation Oncologist-doing locums & live in areaStrong prove-up correlated by cancer incidence rateSupport of local referring physicians, hospital non-competePatients had to travel 1+ hrs for radiation therapy.Physician owned property across from hospital.Building, leaseholds, working capital provided by SBA loan

Funding Provided: $2,800,000.00Equipment: New TomoTherapy SystemStructure: Term: 84 months

Payments: 1-4 @ $05-8 Low payments9-84 Level payments fully amortizing.

Credit Enhancements: PG of PhysicianKey man Life, disability insurance on PhysicianSubordination of distributionsLien on second homeSupportive letter from hospital provided

Sample Transaction #5Sample Transaction #5

24

Transaction: Takeover operations and equipment purchase of financially troubled cancer treatment facility

Funding Provided: $1.425MEquipment: One year old Siemens Primus IMRT System

One year old Philips Diamond Select Special CT

Structure: Term Loan -78 monthsPayments – months 1-3 @ 0; months 4 -78 level payments fully amortizingWorking capital- 48 months with12 months interest only and 36 months level payments fully amortizing

• Purpose: Finance JV between developer and one medical oncologist purchasing financially troubled cancer treatment center located at the cancer treatment medical facility of a hospital

• Lender provided a $1.1M term loan and a $325k for working capital• Customer provided $50k in working capital• Transaction secured by corporate guarantees of the owners on a pro-rata basis and

joint and several personal guarantees of the developer and the medical oncologist. The combined guarantee amount is limited to $490k

Sample Transaction #6Sample Transaction #6

Page 13: Financing Development and Expansion

13

25

Transaction: New JV between two hospitals 60%/40% ownership Cancer center located on hospital campus10 year non-compete agreement 20 mile radiusLimited local competitionJV provided $2M in working capital.Both hospitals strong financiallyBuilding and leaseholds funded by bank financingProve-up correlated by feasibility study, cancer incidence rateStrong support by community and hospital physicians

Funding Provided: $4,280,000.00Equipment: New Varian Trilogy System

New GE 16/S CTStructure: Term: 84 months

Credit Enhancements: Subordination of distributions to JV Ownership

Sample Transaction #7Sample Transaction #7

26

Questions?Questions?

Page 14: Financing Development and Expansion

14

27

Peter MyhreChief Executive OfficerMarCap Corporation

200 West Jackson Blvd.Suite 2000

Chicago, IL 60606Tel: 800.621.1677

[email protected]

Contact UsContact UsGrant Chamberlain

Managing DirectorShattuck Hammond Partners

311 S. Wacker DriveSuite 2010

Chicago, IL 60606Tel: 312.541.6403

[email protected]


Recommended